Pfizer vaccine moves closer to getting the OK in the United States
The encouraging developments come as the coronavirus continues surging across much of the world. The scourge has claimed more than 1.5 million lives, including over 285,000 in the US, the highest toll of any country. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 9, 2020 Category: Pharmaceuticals Source Type: news

Bharat Biotech's intranasal vaccine to enter phase I/II trials by month-end
Vaccine producer Bharat Biotech International (BBIL) could begin phase I/II human clinical trials for its single-dose intranasal vaccine candidate for Covid-19 by the end of December or early next month, its chairman, Krishna Ella, said on Tuesday. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 9, 2020 Category: Pharmaceuticals Source Type: news

Aurobindo Pharma gets USFDA nod for sedative drug
Drug major Aurobindo Pharma On Wednesday said it has received final approval from the US health regulator for generic of Precedex injection, used for sedation of patients. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 9, 2020 Category: Pharmaceuticals Source Type: news

Roche links with Moderna to include antibody test in COVID-19 vaccine trial
Roche said the test can provide quantitative evidence of the presence and levels of antibodies that develop in response to the vaccine candidate. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 9, 2020 Category: Pharmaceuticals Source Type: news

Serum Institute likely to supply Covid vaccine at Rs 250 a dose to the government: Media reports
The government is pinning its hopes for mass supply on Serum Institute, which lodged the first formal application for emergency-use approval of AstraZeneca's shot on Monday. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 8, 2020 Category: Pharmaceuticals Source Type: news

Nations must address barriers against access to affordable medicines, new technologies: India at UN
The 193-member General Assembly decided by consensus to proclaim December 27 as the 'International Day of Epidemic Preparedness' - a day to highlight the importance of the prevention of, preparedness for and partnerships against epidemics such as COVID-19. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 8, 2020 Category: Pharmaceuticals Source Type: news

Indoco Remedies wins tenders worth Rs 140 crore for supply of kidney stones treatment drug in Germany
Aditi Kare Panandikar, Managing Director - Indoco Remedies said: "This is Indoco's first own label product in Europe. Germany is totally tender business and Indoco has won almost 80 - 85 per cent tenders for Allopurinol. This is a tender order for supplies spread over two years". (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 8, 2020 Category: Pharmaceuticals Source Type: news

Piramal Pharma Solutions invests around USD 32 mn to expand Michigan facility
The expansion is planned to be ready for customers beginning summer 2022. It is expected that the expansion will add around twenty new hires to the site, bringing the total headcount to more than 180 employees and further benefiting the local economy, it added. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 8, 2020 Category: Pharmaceuticals Source Type: news

India may authorise some COVID-19 vaccines in weeks, says health secretary
Six vaccines, including Astra Zeneca's Covidshield and Bharat Biotech's Covaxin, are in trial stages, Federal health secretary Rajesh Bhushan told a press conference. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 8, 2020 Category: Pharmaceuticals Source Type: news

COVID vaccines in India: 6 candidates in different trial stages, 3 may get licensed in 'next few weeks'
(Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 8, 2020 Category: Pharmaceuticals Source Type: news

Bharat Biotech's intranasal COVID-19 vaccine to enter phase 1 trials next month
Replying to a query on the probable pricing of Covaxin, he said Indian vaccines will be much cheaper when compared to other countries. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 8, 2020 Category: Pharmaceuticals Source Type: news

Covid-19: India pins hopes on 4 vaccines to inoculate 30 crore by July
While Covishield, according to a PTI report late on Sunday evening, sought emergency approval, Covaxin is expected to be approved for emergency use by the end of January or early February, if the shots clear scrutiny. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 7, 2020 Category: Pharmaceuticals Source Type: news

Covid-19: Serum Institute seeks emergency authorisation for Oxford vaccine Covishield in India
(Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 7, 2020 Category: Pharmaceuticals Source Type: news

Zydus Cadila gets permission from DCGI for phase-1 clinical trial of novel molecule ZYIL1
Drug firm Zydus Cadila on Monday said it has received permission from Drugs Controller General of India (DCGI) to initiate phase-1 clinical trial of its novel molecule ZYIL1, indicated for use as an inhibitor for inflammation condition 'NLRP3'. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 7, 2020 Category: Pharmaceuticals Source Type: news

COVID-19 vaccine clinical trials: 17 volunteers given doses of Russia's Sputnik V in Pune
Sputnik V vaccine has been developed by the Gamaleya National Research Center of Epidemiology and Microbiology and Russian Direct Investment Fund (RDIF). As per reports, India has purchased 100 million doses of the candidate from Russia. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 6, 2020 Category: Pharmaceuticals Source Type: news

Medicine traders flag crisis of essential medicines due to farmers' agitation
Amid the siege on the capital by farmers protesting against the newly-formed agrarian laws by the Centre on its various borders, the All India Organisation of Chemists and Druggists (AIOCD) has expressed concerns about the possibility of a shortage of essential medicines as the road transportation has been hampered in north India. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 6, 2020 Category: Pharmaceuticals Source Type: news

After Haryana's Anil Vij tests positive, Bharat Biotech says COVAXIN efficacious, safe
"COVAXIN clinical trials are based on a two-dose schedule, given 28 days apart. The vaccine efficacy will be determined 14 days after the second dose. COVAXIN has been designed to be efficacious when subjects receive both the doses," Bharat Biotech said in a statement. The Haryana minister tested positive for novel coronavirus, around two weeks after he was administered the first trial dose of Bharat biotech vaccine candidate, COVAXIN. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 5, 2020 Category: Pharmaceuticals Source Type: news

COVID-19: Zydus Cadila gets DGCI nod for phase 3 clinical trials with biological therapy
The company had completed the phase 2 clinical trials with PegiHep last month. In a regulatory filing, Zydus Cadila said it has received approval from the DCGI to start the phase 3 clinical trials in COVID-19 patients with its biological therapy Pegylated Interferon alpha-2b or PegiHep. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 4, 2020 Category: Pharmaceuticals Source Type: news

Important to have large basket of COVID-19 vaccine candidates: DBT Secretary
Department of Biotechnology secretary Renu Swarup said the vaccines that are being developed indigenously are on different platforms and each has its own benefits and challenges. "It is not necessary that the first one is the best, you may have one coming later which is going to be better but it is difficult to say right now," she said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 4, 2020 Category: Pharmaceuticals Source Type: news

Price of Remdesivir injection fixed at Rs 2,360 in Maharashtra
The government has also put together a list of 59 pharmaceutical outlets where it can be purchased, covering all the major cities, towns and districts, said Dr Pradeep Vyas, principal secretary, public health and family welfare. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 4, 2020 Category: Pharmaceuticals Source Type: news

India biggest buyer of COVID-19 vaccine with 1.6 bn doses, experts say this could cover 60% population
India has purchased 500 million doses of the Oxford University-AstraZeneca vaccine candidate, one billion from the US company Novavax and 100 million doses of the Sputnik V candidate from Russia's Gamaleya Research Institute, according to the US-based Duke University Global Health Innovation Center. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 4, 2020 Category: Pharmaceuticals Source Type: news

India will wait for Oxford and Bharat Biotech shots
The government is keenly watching developments in Oxford-AstraZeneca candidate for which Serum Institute is the local partner and has said it will apply for emergency use authorisation in next few days. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 3, 2020 Category: Pharmaceuticals Source Type: news

5 Covid vaccines undergoing trial in India logistically feasible for distribution in both urban, rural areas: AIIMS director
Dr Guleria expressed hope that by the end of this month or early next month, at least one of the five vaccines being locally-tested should get emergency use authorisation from the drug regulator to be administered to the public starting with priority groups. According to sources, global pharma giant Pfizer had talks with the Indian government late August, but since then there has been no development. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 3, 2020 Category: Pharmaceuticals Source Type: news

Committed to engaging with Indian govt to make vaccine available in country: Pfizer
The UK on Wednesday became the first country to approve the Pfizer/BioNTech vaccine against COVID-19 with the UK regulator Medicines and Healthcare products Regulatory Agency (MHRA)granting a temporary authorisation for its emergency use. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 3, 2020 Category: Pharmaceuticals Source Type: news

India will wait for Oxford and Bharat Biotech shots
The Pfizer-BioNTech Covid-19 vaccine is not available for India at present and its requirement for ultra-cold temperature — minus 70 degree Celsius (minus 94 degrees Fahrenheit) — for storage is a serious hurdle as the vaccine will need to be distributed in remote areas and even urban centres lack such facilities. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 3, 2020 Category: Pharmaceuticals Source Type: news

Alembic Pharma receives USFDA approval for Metolazone tablets
The approved product is therapeutically equivalent to the reference listed drug product Zaroxolyn Tablets 2.5 mg, 5 mg and 10 mg of Lannett Company, Inc. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 3, 2020 Category: Pharmaceuticals Source Type: news

Phase-3 clinical trial of Covaxin commences in Kolkata
The governor further said that the Centre's Ayushman Bharat scheme, which provides free healthcare services, has provided succour to many amid the crisis. Notably, the scheme has not been implemented in West Bengal so far. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 2, 2020 Category: Pharmaceuticals Source Type: news

Rhizen Pharmaceuticals gets USFDA approval for phase one clinical trials for Covid-19 drug
The Switzerland-based firm, which is a clinical-stage oncology-focussed biopharmaceutical company, has received approval for its investigational new drug (IND) application from the US Food and Drug Administration (FDA) to study its oral Dihydroorotate dehydrogenase (DHOHD) inhibitor for SARS-CoV-2 infection, Rhizen Pharmaceuticals S A said in a statement. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 2, 2020 Category: Pharmaceuticals Source Type: news

Pfizer/BioNTech's Covid-19 vaccine: How the mRNA technology works
The UK health secretary, Matt Hancock, tweeted that the NHS stands ready to start vaccinating early next week. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 2, 2020 Category: Pharmaceuticals Source Type: news

Who will get COVID-19 vaccine first in the world
(Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 2, 2020 Category: Pharmaceuticals Source Type: news

Dr Reddy's Labs begins phase 2/3 trials for Russia's Sputnik V COVID-19 vaccine
JSS Medical Research was roped in as clinical partner to conduct the multi-centre and randomised controlled study that includes safety and immunogenicity study, Dr Reddy's& RDIF said in a joint statement. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 2, 2020 Category: Pharmaceuticals Source Type: news

When and which COVID-19 vaccines are likely to be available in Asia
Trial data from Pfizer Inc with partner BioNTech SE, Moderna Inc and AstraZeneca Plc has shown their experimental vaccines are effective in preventing the coronavirus. If regulators approve any in coming weeks, the companies have said distribution could begin almost immediately. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 1, 2020 Category: Pharmaceuticals Source Type: news

Glenmark Pharma gets tentative nod from USFDA for cancer treatment drug
Glenmark Pharmaceuticals has received tentative approval by the United States Food& Drug Administration (USFDA) for Axitinib tablets in the strength of 1 mg and 5 mg, the company said in a regulatory filing. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 1, 2020 Category: Pharmaceuticals Source Type: news

Aurobindo Pharma completes sale of Natrol LLC to New Mountain Capital
Natrol's annual sales for the 12 months ended March 31, 2020, stood at around USD 157 million. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 1, 2020 Category: Pharmaceuticals Source Type: news

SeQuent Scientific launches veterinary medicine in 19 European countries
The product had recently received approval from European Medicines Agency (EMA) through its Spanish subsidiary Laboratorios Karizoo, S A, the company added. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 1, 2020 Category: Pharmaceuticals Source Type: news

We won ’t release Covishield for mass use until it's proven safe and immunogenic: SII
"The incident with the Chennai volunteer though highly unfortunate was in no way induced by the vaccine and SII is sympathetic with the volunteer's medical condition. However, we would like to clarify that all the requisite regulatory and ethical processes and guidelines were followed," SII said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 1, 2020 Category: Pharmaceuticals Source Type: news

COVID-19: Wockhardt in discussions with vaccine developers to offer drug substance
According to the company, the UK government has reserved one fill and finish production line at Wockhardt UK for its exclusive use for 18 months in order to guarantee the supply of vaccines required to fight against COVID-19. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 1, 2020 Category: Pharmaceuticals Source Type: news

Divi's Lab earmarks Rs 1,500 cr to set up manufacturing facility in Andhra Pradesh
Drugmaker Divi's Laboratories on Tuesday said it has earmarked Rs 1,500 crore to set up a new manufacturing facility in Andhra Pradesh. The work on the manufacturing plant would commence from December 7, Divi's Laboratories said in a regulatory filing. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 1, 2020 Category: Pharmaceuticals Source Type: news

BioNTech, Pfizer ask Europe to quickly approve virus vaccine
The German pharmaceutical company BioNTech and its U.S. partner Pfizer say they have submitted an application for speeded-up, conditional approval of their coronavirus vaccine with the European Medicines Agency. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 1, 2020 Category: Pharmaceuticals Source Type: news

Initial findings into 'adverse event' did not necessitate halting of trials: Govt
A 40-year-old man who was a volunteer in the third phase of the ''Covidshield'' vaccine trial in Chennai has alleged serious side effects, including a virtual neurological breakdown and impairment of cognitive functions. He has sought Rs 5 crore compensation in a legal notice to Serum Institute and others, besides seeking a halt to the trial. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 1, 2020 Category: Pharmaceuticals Source Type: news

AstraZeneca partner sticks with two full dose regimen in Covid trials in India
The British drugmaker has said its Covid-19 vaccine could be up to 90% effective if administered as a half dose followed by a full dose, but some scientists have questioned the robustness of that result because only a few thousand people were given that regimen in late-stage UK trials. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 1, 2020 Category: Pharmaceuticals Source Type: news

Mankind Pharma announces Mohanlal as corporate brand ambassador
Rajeev Juneja, CEO of Mankind Pharma, said the pharma company has been recognising the real heroes of society and it really wanted to associate with a familiar face who is a changemaker. "Mohanlal is a real fit as the corporate brand ambassador for Mankind Pharma. We believe in giving back to the society through our CSR activities and thereby lending a helping hand to the ones in need." (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 30, 2020 Category: Pharmaceuticals Source Type: news

Auto-disable syringes are the best option to prevent reuse: HS Ratti, epidemiologist
"Companies making these syringes have large capacities. They should be able to supply the desired quantity. There are regular training programs conducted across states to train medical staff in areas of safe injection practices. Well-trained nurses and paramedics should be able to administer injections using AD syringes. The process is almost the same." (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 30, 2020 Category: Pharmaceuticals Source Type: news

Serum Institute rejects charges levelled by vaccine trial participant, will seek Rs 100 crore in damages
A 40-year-old man who took part in the 'Covidshield' vaccine trial in Chennai has alleged serious side effects, including a virtual neurological breakdown and impairment of cognitive functions and has sought Rs 5 crore compensation in a legal notice to Serum Institute and others, besides seeking a halt to the trial. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 29, 2020 Category: Pharmaceuticals Source Type: news

Serum Institute rejects charges levelled by vaccine trial participant, threatens to seek damages
A 40-year-old man who took part in the 'Covidshield' vaccine trial in Chennai has alleged serious side effects, including a virtual neurological breakdown and impairment of cognitive functions and has sought Rs 5 crore compensation in a legal notice to Serum Institute and others, besides seeking a halt to the trial. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 29, 2020 Category: Pharmaceuticals Source Type: news

Pharma hiring to remain conservative despite pace in vaccine development: Study
The top 25 pharma brands by size have a total active job openings count of about 4,500 jobs globally and only 6% of these active openings are currently open in India, according to the study on human capital and job information. The data collected for the study is from top job boards, company career pages, and official company pages on social media. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 28, 2020 Category: Pharmaceuticals Source Type: news

Gujarat: PM Modi reviews vaccine development at Zydus Cadila facility
After his arrival at Ahmedabad airport from Delhi shortly after 9 am, Modi flew to the Zydus Cadila plant and held discussions with the promoters and executives of the company, an official said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 28, 2020 Category: Pharmaceuticals Source Type: news

PM's presence to motivate company in quest to bridge unmet healthcare needs: Zydus Cadila
The Zydus family comprising 25,000 Zydans stands committed to the 'Aatmanirbhar Bharat' mission and offering the nation safe and efficacious vaccines, therapeutics and diagnostics to fight COVID-19, said the company. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 28, 2020 Category: Pharmaceuticals Source Type: news

PM Modi visits Bharat Biotech's vaccine manufacturing facility in Hyderabad
Covaxin, being developed by Bharat Biotech in collaboration with the Indian Council of Medical Research and National Institute of Virology, is now undergoing phase-3 trials. The Phase-3 trials involve 26,000 volunteers across India, conducted in partnership with ICMR. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 28, 2020 Category: Pharmaceuticals Source Type: news

SII to seek emergency use authorisation for AstraZeneca Covid vaccine in 2 weeks: Poonawalla
Adar Poonawalla, Founder and CEO, SII said on Saturday that SII is in the process of submitting the data for the clinical trials to the DCGI and will seek emergency use authorisation. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 28, 2020 Category: Pharmaceuticals Source Type: news